Skip to main content
SpringerLink
Log in

Stellenwert von PD-L1 als Biomarker für die immunonkologische Therapie beim Lungenkarzinom

  • Sektion C
  • Published:
Forum Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Karasaki T et al (2017) An Immunogram for the Cancer-Immunity Cycle: Towards Personalized Immunotherapy of Lung Cancer. J Thorac Oncol 11. doi:10.1016/j.jtho.2017.01.005

    Article  PubMed  Google Scholar 

  2. NIH Biomarkers Definition Working Group (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Therapeutics 69:89–95

    Article  Google Scholar 

  3. Oldenhuis CN et al (2008) Prognostic versus predictive value of biomarkers in oncology. Eur J Cancer 44:946–953

    Article  CAS  PubMed  Google Scholar 

  4. Onkopedia Leitlinie „Lungenkarzinom, nicht-kleinzellig (NSCLC)“; Stand: 11/2016. Online unter www.onkopedia.com

  5. Postow MA et al (2015) Immune checkpoint blockade in cancer therapy. J Clin Oncol 33:1974–1982

    Article  CAS  PubMed Central  Google Scholar 

  6. Fife BT, Bluestone JA (2008) Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 224:166–182

    Article  CAS  PubMed  Google Scholar 

  7. Patel SP, Kurzrock R (2015) PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy. Mol Cancer Ther 14:847–856

    Article  CAS  Google Scholar 

  8. Blank CU et al (2016) CANCER IMMUNOLOGY. The “cancer immunogram”. Science 352:658–660

    Article  CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stellenwert von PD-L1 als Biomarker für die immunonkologische Therapie beim Lungenkarzinom. Forum 32, 364–365 (2017). https://doi.org/10.1007/s12312-017-0276-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12312-017-0276-0

Search

Navigation